CP and infection: In light of the emergence of variant SARS-CoV-2 strains, CP donated by survivors of infections with variant strains is an immediately deployable treatment option for patients who have been identified as having a variant infection, whereas other immune treatments may require (re)development of more specific mechanisms to target new viral strains.176, 177, 178